James E. Balow

21.3k total citations · 5 hit papers
133 papers, 11.7k citations indexed

About

James E. Balow is a scholar working on Rheumatology, Immunology and Nephrology. According to data from OpenAlex, James E. Balow has authored 133 papers receiving a total of 11.7k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Rheumatology, 48 papers in Immunology and 36 papers in Nephrology. Recurrent topics in James E. Balow's work include Systemic Lupus Erythematosus Research (62 papers), Renal Diseases and Glomerulopathies (34 papers) and Liver Diseases and Immunity (18 papers). James E. Balow is often cited by papers focused on Systemic Lupus Erythematosus Research (62 papers), Renal Diseases and Glomerulopathies (34 papers) and Liver Diseases and Immunity (18 papers). James E. Balow collaborates with scholars based in United States, Greece and Israel. James E. Balow's co-authors include Howard A. Austin, Dimitrios T. Boumpas, John H. Klippel, John L. Decker, Ellen M. Vaughan, Gabor G. Illei, Larry R. Muenz, Kathleen Joyce, Sharda G. Sabnis and Cheryl Yarboro and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

James E. Balow

132 papers receiving 11.1k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Enzyme Replacement Therapy in Fabry Disease

2001 1.0k citations Raphael Schiffmann, Jeffrey B. Kopp et al. JAMA profile →
Therapy of Lupus Nephritis

1986 863 citations Howard A. Austin, John H. Klippel et al. New England Journal of Medicine profile →
Prognostic factors in lupus nephritis

1983 611 citations Howard A. Austin, Larry R. Muenz et al. profile →
Diffuse proliferative lupus nephritis: Identification of specific pathologic features affecting renal outcome

1984 587 citations Howard A. Austin, Larry R. Muenz et al. Kidney International profile →
Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis

1992 579 citations Dimitrios T. Boumpas, H A Austin et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James E. Balow United States	50	6.2k	3.8k	3.4k	1.7k	1.6k	133	11.7k
Jean‐Charles Piette France	69	6.0k 1.0×	2.9k 0.8×	1.2k 0.4×	2.0k 1.2×	2.0k 1.3×	201	14.1k
Graham R.V. Hughes United Kingdom	68	13.6k 2.2×	4.4k 1.2×	1.7k 0.5×	811 0.5×	1.2k 0.7×	263	18.2k
Dimitrios T. Boumpas Greece	69	7.3k 1.2×	7.4k 2.0×	1.7k 0.5×	714 0.4×	2.6k 1.6×	317	15.5k
Tatsuya Atsumi Japan	51	9.5k 1.5×	4.2k 1.1×	1.7k 0.5×	678 0.4×	1.8k 1.1×	512	15.5k
D Alarcón-Segovia Mexico	56	7.3k 1.2×	4.4k 1.2×	773 0.2×	870 0.5×	1.1k 0.7×	342	12.3k
Jill P. Buyon United States	74	9.8k 1.6×	7.1k 1.9×	1.5k 0.4×	853 0.5×	2.0k 1.3×	320	17.1k
Robert T. McCluskey United States	50	2.5k 0.4×	2.3k 0.6×	2.2k 0.7×	1.8k 1.1×	1.8k 1.2×	173	10.6k
Leendert A. van Es Netherlands	51	2.5k 0.4×	4.1k 1.1×	3.1k 0.9×	1.7k 1.0×	1.7k 1.1×	235	12.0k
Jane E. Salmon United States	66	7.8k 1.3×	6.8k 1.8×	1.9k 0.6×	434 0.3×	1.7k 1.1×	211	14.6k
Naomi F. Rothfield United States	48	12.7k 2.1×	7.8k 2.1×	1.6k 0.5×	683 0.4×	2.7k 1.7×	125	19.8k

Countries citing papers authored by James E. Balow

Since Specialization

Citations

This map shows the geographic impact of James E. Balow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James E. Balow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James E. Balow more than expected).

Fields of papers citing papers by James E. Balow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James E. Balow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James E. Balow. The network helps show where James E. Balow may publish in the future.

Co-authorship network of co-authors of James E. Balow

This figure shows the co-authorship network connecting the top 25 collaborators of James E. Balow. A scholar is included among the top collaborators of James E. Balow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James E. Balow. James E. Balow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hasni, Sarfaraz, Sarthak Gupta, Michael A. Davis, et al.. (2018). Safety and Tolerability of Omalizumab: A Randomized Clinical Trial of Humanized Anti‐IgE Monoclonal Antibody in Systemic Lupus Erythematosus. Arthritis & Rheumatology. 71(7). 1135–1140. 49 indexed citations

Balow, James E., John Ryan, Jae Jin Chae, et al.. (2012). Microarray-based gene expression profiling in patients with cryopyrin-associated periodic syndromes defines a disease-related signature and IL-1-responsive transcripts. Annals of the Rheumatic Diseases. 72(6). 1064–1070. 21 indexed citations

Zhou, Hua, Anita Cheruvanky, Xuzhen Hu, et al.. (2008). Urinary exosomal transcription factors, a new class of biomarkers for renal disease. Kidney International. 74(5). 613–621. 208 indexed citations

Ravin, Suk See De, Nora Naumann, Edward W. Cowen, et al.. (2008). Chronic granulomatous disease as a risk factor for autoimmune disease. Journal of Allergy and Clinical Immunology. 122(6). 1097–1103. 159 indexed citations

Javor, Edward D., Janice Ryan Young, Elaine Cochran, et al.. (2004). Proteinuric Nephropathy in Acquired and Congenital Generalized Lipodystrophy: Baseline Characteristics and Course during Recombinant Leptin Therapy. The Journal of Clinical Endocrinology & Metabolism. 89(7). 3199–3207. 82 indexed citations

Branton, Mary H., Raphael Schiffmann, Sharda G. Sabnis, et al.. (2002). Natural History of Fabry Renal Disease. Medicine. 81(2). 122–138. 352 indexed citations

Schiffmann, Raphael, Jeffrey B. Kopp, Howard A. Austin, et al.. (2001). Enzyme Replacement Therapy in Fabry Disease. JAMA. 285(21). 2743–2743. 1008 indexed citations breakdown →

Balow, James E., Dimitrios T. Boumpas, & H A Austin. (2000). New prospects for treatment of lupus nephritis.. PubMed. 20(1). 32–9. 16 indexed citations

Grande, Joseph P. & James E. Balow. (1998). Renal biopsy in lupus nephritis. Lupus. 7(9). 611–617. 67 indexed citations

10.

Anastassiou, Evangelos D., Hidehiro Yamada, Dimitrios T. Boumpas, et al.. (1992). Cholera toxin promotes the proliferation of anti-μ antibody-prestimulated human B cells. Cellular Immunology. 140(1). 237–247. 5 indexed citations

11.

Balow, James E.. (1990). Treatment and Monitoring of Patients with Lupus Nephritis. Nephrology Dialysis Transplantation. 5(suppl 1). 58–59. 5 indexed citations

12.

Boumpas, Dimitrios T., et al.. (1989). Transcriptional and post-transcriptional mechanisms are responsible for the increased expression of c-myc protooncogene in lymphocytes from patients with systemic lupus erythematosus. Clinical Immunology and Immunopathology. 52(3). 507–515. 11 indexed citations

13.

Inghirami, Giorgio, Motoki Nakamura, James E. Balow, Abner Louis Notkins, & Paolo Casali. (1988). Model for studying virus attachment: identification and quantitation of Epstein-Barr virus-binding cells by using biotinylated virus in flow cytometry. Journal of Virology. 62(7). 2453–2463. 70 indexed citations

14.

Austin, Howard A., John H. Klippel, James E. Balow, et al.. (1986). Therapy of Lupus Nephritis. New England Journal of Medicine. 314(10). 614–619. 863 indexed citations breakdown →

15.

Inghirami, Giorgio, Julie Y. Djeu, James E. Balow, & George C. Tsokos. (1985). Enhancement of Human Allogeneic Cytotoxic Responses by Interferons. PubMed. 7(4). 403–415. 4 indexed citations

16.

Tsokos, George C. & James E. Balow. (1985). Immunosuppressive Agents and Plasmapheresis in Immunological Disorders. PubMed. 7(1). 1–15. 9 indexed citations

17.

Balow, James E.. (1985). Renal vasculitis. Kidney International. 27(6). 954–964. 68 indexed citations

18.

Austin, Howard A., Larry R. Muenz, Kathleen Joyce, Tatiana T. Antonovych, & James E. Balow. (1984). Diffuse proliferative lupus nephritis: Identification of specific pathologic features affecting renal outcome. Kidney International. 25(4). 689–695. 587 indexed citations breakdown →

19.

Tsokos, George C. & James E. Balow. (1981). Cytotoxic responses to alloantigens in systemic lupus erythematosus. Journal of Clinical Immunology. 1(4). 208–216. 13 indexed citations

20.

Balow, James E. & Alan S. Rosenthal. (1973). GLUCOCORTICOID SUPPRESSION OF MACROPHAGE MIGRATION INHIBITORY FACTOR. The Journal of Experimental Medicine. 137(4). 1031–1041. 179 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact